Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about CVS HEALTH
10/19 EXPRESS SCRIPTS : Anthem will turn to CVS for prescriptions
10/19 EXPRESS SCRIPTS : Anthem to turn to CVS after troubled deal
10/19DJAnthem To Launch Pharmacy Benefit Manager -- WSJ
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--3rd Update
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--2nd Update
10/18 MARKETS RIGHT NOW : US stocks closing higher; IBM surges
10/18 Anthem will turn to CVS after troubled Express Scripts deal
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--2nd Update
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--Update
10/18DJAnthem Signs Five-Year Deal With CVS for Services to New Pharmacy-Benefit Man..
10/18 CVS HEALTH : Signs Five-Year Agreement with Anthem, Inc. to Provide Services to ..
10/17 CVS PHARMACY : Encourages Patients to Check Their Meds on "National Check Your M..
10/16 CVS HEALTH : and Epic Announce Initiative to Help Lower Drug Costs for Patients ..
10/16 CVS HEALTH : Monroe County, CVS split victories in tax court
10/12 CATCH GLOBAL FOUNDATION : And CVS Health Team Up To Curb Youth E-Cigarette Use
More most relevant news
All news about CVS HEALTH
01:39p Rep. Cummings Requests Documents From Top Insurers and Pharmacy Benefit Manag..
10/20 CVS HEALTH : Dividend Coverage: This Pharmacy Company has a Dividend Yield of 2...
10/19 CVS HEALTH : SilverScript Insurance Company, a CVS Health Company, Introduces Ne..
10/19 EXPRESS SCRIPTS : Anthem will turn to CVS for prescriptions
10/19 EXPRESS SCRIPTS : Anthem to turn to CVS after troubled deal
10/19DJAnthem To Launch Pharmacy Benefit Manager -- WSJ
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--3rd Update
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--2nd Update
10/18 MARKETS RIGHT NOW : US stocks closing higher; IBM surges
10/18 Anthem will turn to CVS after troubled Express Scripts deal
More news
Sector news : Drug Retailers - NEC
10/19DJAnthem To Launch Pharmacy Benefit Manager -- WSJ
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--3rd Update
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--2nd Update
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--2nd Update
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--Update
10/18DJAnthem Signs Five-Year Deal With CVS for Services to New Pharmacy-Benefit Man..
More sector news : Drug Retailers - NEC
News from SeekingAlpha
10/19 Dividend Growth Stocks Going Ex-Div October 23th-27th
10/19 Stocks Going Ex-Dividend The Fourth Week Of October
10/18 PHARMACY BEARS : High On Drugs
10/18 CVS Health inks five-year deal with Anthem to support PBM unit; shares up 2% ..
10/17 A REAL DIVIDEND GROWTH MACHINE : Q3 2017 Portfolio Review
10/17 WALGREENS PICK UP : Sell-Off Offers 40% Upside
Latest Tweets
10:52aCVS Health Corporation $CVS Shares Sold by BRITISH COLUMBIA INVESTMENT MANAGE.. 
10:46aCVS Health Corporation $CVS Stake Increased by Savant Capital LLC  
10/20MU has a $20,000 grant from American Cancer Society & CVS Health Foundati.. 
10/20Anthem teams up with CVS Health to launch its pharmacy benefits manager busin..
3
10/20CVS Health Corporation $CVS Shares Sold by Pinnacle Financial Partners Inc.  
More tweets
Qtime:224
Financials ($)
Sales 2017 184 B
EBIT 2017 10 051 M
Net income 2017 5 266 M
Debt 2017 24 750 M
Yield 2017 2,55%
P/E ratio 2017 15,12
P/E ratio 2018 13,14
EV / Sales 2017 0,56x
EV / Sales 2018 0,53x
Capitalization 77 757 M
Chart CVS HEALTH
Duration : Period :
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 86,7 $
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH-5.42%77 757
WALGREENS BOOTS ALLIANCE-18.15%72 831
EXPRESS SCRIPTS HOLDING CO-16.02%34 370
MCKESSON CORPORATION6.77%31 703
CARDINAL HEALTH INC-10.10%21 028
AMERISOURCEBERGEN CORP.5.13%18 232